Clinical Trial Update: Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot trial of KB001 in mechanically ventilated patients colonized with Pseudomonas aeruginosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection
• Ventilator-associated Pneumonia

Drugs mentioned

• KB001

Snippet

Sponsor: Humanigen, Inc. | Conditions: Pseudomonas Aeruginosa, Ventilator Associated Pneumonia | Phase 1, Phase 2 | Status: COMPLETED